semaglutide and heart failure in Patients with with Preserved Ejection Fraction Obesity Oral Semaglutide Reduces Heart Failure

Evidence suggests that GLP-1 pathways influence the central nervous system via multiple routes: some agents and/or their downstream effects reach or affect the brain and bloodbrain barrier , altering glucose transport, microglial activation, and synaptic function in preclinical and early human studies

Both of these effects were canceled in the presence of an antagonist of melanocortin receptors 3 and 4, confirming receptor-mediated mechanisms

Exenatide and lixisenatide are exendin 4-based agents, while albiglutide, dulaglutide, liraglutide, and semaglutide are GLP-1-based agents

Flow cytometry and histology revealed that this treatment converted the TAM population from an immunosuppressive to an immunogenic state

Is a GLP-1 Medication Right for You